Catalyst Wire Dossier Catalyst Wire Dossier

Arbaclofen Placabril

arbaclofen placarbil · XenoPort, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Arbaclofen Placabril, covering 2021-02-21 to 2021-02-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Arbaclofen Placarbil (XP19986) in Subjects With Acute Back Spasms [Phase 2]

See pricing